Shots: Shots:

• The company receives EUA for its Novodiag COVID-19 molecular diagnostic test used to detect SARS-CoV-2 virus rapidly and is now available in Finland and under process for obtaining EUA in Sweden- UK and France
• The Novodiag COVID-19 assay qualitatively detects SARS-CoV-2 (orf1ab and N genes) directly from nasopharyngeal swabs and will operate using the Novodiag rapid ‘sample-in- result-out’ system- allowing the fully automated detection of COVID-19 in ~1hr.
• The new test complements the emergency use test- Amplidiag COVID-19- suitable for high-throughput screening and was launched on Apr 14- 2020- with its availability in Finland and France

Click here ­to­ read full press release/ article | Ref: Mobidiag | Image: Mobidiag